Home \ Neurology \ Mexidol® for chronic cerebral ischemia/cerebrovascular insufficiency

Mexidol® for chronic brain ischemia / discirculatory encephalopathy

The brain in focus of arterial hypertension

Peculiarities of managing elderly patients

The brain is a key target organ for treatment of cerebrovascular risks

Mexidol as a geroprotector: potential and prospects

Neuroprotection in arterial hypertension and cognitive impairment

The Connection Between Vascular Diseases of the Brain and Eye: A Neurologist and Ophthalmologist's Perspective

Ischemic stroke: clinical guidelines and practical aspects

NIHSS and mRS: Gold Standards in Neuroscience

Cognitive impairment caused by arterial hypertension: from clinical guidelines to practical algorithms

The brain is a target organ for arterial hypertension: features of management of the elderly patient

Time codes:
  • 00:00

    Pathogenesis of chronic brain ischemia

  • 00:33

    The causes of chronic brain ischemia

  • 01:07

    Mexidol® drug with brain ischemic

Lyubov Petrovna Sokolova – Doctor of Medical Sciences, Professor of the Department of Neurology, Faculty of Continuing Professional Education, N.I. Pirogov Russian National Research Medical University

Announcement:

Chronic cerebral ischemia is a condition characterized by a mismatch between the blood supply to brain tissue and its need for oxygen and nutrients. This condition can arise due to cerebral atherosclerosis and stenosis, as well as microangiopathy associated with hypertension. Endothelial dysfunction, neurogenic inflammation, and oxidative stress all contribute to inadequate tissue blood supply. A drug that addresses all these factors is essential. Mexidol®is the drug of choice because it has antihypoxic, antioxidant, and membrane-protective effects. It influences vascular risk factors, hyperglycemia, and hypertension to some extent. It has nootropic, anxiolytic, and anti-anxiety effects, and normalizes sleep. It also has a geroprotective effect. Mexidol®is the drug of choice for the treatment of chronic cerebral ischemia.

All videos Next video

The brain in focus of arterial hypertension

Peculiarities of managing elderly patients

The brain is a key target organ for treatment of cerebrovascular risks

Mexidol as a geroprotector: potential and prospects

Neuroprotection in arterial hypertension and cognitive impairment

The Connection Between Vascular Diseases of the Brain and Eye: A Neurologist and Ophthalmologist's Perspective

Ischemic stroke: clinical guidelines and practical aspects

NIHSS and mRS: Gold Standards in Neuroscience

Cognitive impairment caused by arterial hypertension: from clinical guidelines to practical algorithms

The brain is a target organ for arterial hypertension: features of management of the elderly patient

Time codes:
  • 00:00

    Pathogenesis of chronic brain ischemia

  • 00:33

    The causes of chronic brain ischemia

  • 01:07

    Mexidol® drug with brain ischemic

Block of articles on this topic

The effectiveness of Mexidol in patients of different age groups with chronic brain ischemia with cognitive disorders (the results of subanalysis of the international multicenter randomized double blind placebo-controlled study of memes)

Authors:
V.V. ZAKHAROV1, O.N. TKACHEV2,3, E.A. MKHITARYAN2,3, A.I. FEDIN2

Read more
Safety Mexidol® (ethylmethylhydroxypyridine of succinate) in adult patients of different age groups

Authors:
E.A. USHKALOVA1, S.K. ZYRYANOV1,2, O.I. BUTRANOVA1

1Federal State Autonomous Educational Institution of Higher Education “Peoples’ Friendship University of Russia”
2State Budgetary Healthcare Institution “City Clinical Hospital No. 24 of the Moscow City Health Department”

Read more
Personal: International multicenter randomized double-tied placebo-controlled study of evaluating the effectiveness and safety of sequential therapy of patients with chronic brain ischemia drugs Mexidol® and Mexidol® Forte 250: Subanalysis results in patients with arterial hypertension

Authors:
V.V. ZAKHAROV1, O.D. OSTROUMOVA1,2, A.I. KOCHETKOV2, M.V. KLEPIKOVA2, A.I. FEDIN3

Read more
The effectiveness and safety of the drug Mexol Forte 250 in the framework of consecutive therapy in patients with chronic brain ischemia

Author:
E.I. CHUKANOVA, A.S. CHUKANOVA

Department of Neurology, Neurosurgery and Medical Genetics of Faculty of Faculty of Faculty of FSBEI in "RNIMU named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia

Read more

THE INFORMATION IS INTENDED FOR HEALTHCARE AND PHARMACEUTICAL PROFESSIONALS. THIS INFORMATION IS NOT INTENDED AS A SUBSTITUTE FOR MEDICAL ADVICE.

Source of photos and images Shutterstock.com